MarginsXMarginsX
Home › Markets › Health Care › BDX

Becton Dickinson and Company (BDX)

BDX trades on NYSE in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$216.47
-0.72% on the day
Market cap
$59.0B
Large cap
Revenue · 2025
$21.8B
+8.2% on 2024
Net income · 2025
$1.7B
7.7% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2025-09-30, https://www.sec.gov/Archives/edgar/data/10795/000001079525000099/0000010795-25-000099-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-09-30.

Profile

FieldValue
TickerBDX on NYSE
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0000010795
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inNJ

Financials · 2025

LineValue
Revenue$21.8B
Net income$1.7B
Operating income$2.6B
Net margin7.7%
Operating margin11.8%
Revenue growth+8.2%
Cash$641.0M
Total assets$55.3B
P/E (computed)35.1×
P/S (computed)2.7×

Warning signs

Cash runway
Cash-flow positive
$708.0M cash at June 30, 2026
Share count, 1 year
-25.3%
2025-06-30 to 2026-06-30 · -26.2% over 3 years
Going-concern doubt
No
10-Q filed August 6, 2026
Insider net buying, 12 months
-$2.8M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-08-06
Cash and burn$708.0M cash; operating cash flow $1.1B a quarter.Report 2026-06-30
Shares outstanding272,386,800 (2026-06-30); 286,627,469 a year earlier; 290,108,574 three years earlier. 1y figure adjusted for splits (1.272-for-1 overall); 3y figure adjusted for splits (1.272-for-1 overall).Cover page 2026-06-30
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
Delisting25-NSE filed25-NSE 2026-06-04
AuditorErnst & Young LLP, New York, New York, United StatesPCAOB Form AP 2025-12-22
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $2.8M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-06-30
$5.0B$377.0M$776.0M$708.0M$16.8B$23.3B10-Q 2026-08-06
Q2 2026
2026-03-31
$4.7B-$311.0MNot filed$813.0M$17.3B$23.0B10-Q 2026-05-07
Q1 2026
2025-12-31
$5.3B$382.0M$657.0M$740.0M$19.5B$22.8B10-Q 2026-02-09
Q4 2025
2025-09-30
$8.3B$493.0M$1.9B$567.0M$19.2B$22.7B10-K 2025-11-25
Q3 2025
2025-06-30
$4.7B$574.0M$1.1B$735.0M$19.3B$19.8B10-Q 2026-08-06
Q2 2025
2025-03-31
$4.5B$308.0M-$204.0M$667.0M$19.3B$20.1B10-Q 2026-05-07
Q1 2025
2024-12-31
$5.2B$303.0M$693.0M$711.0M$18.8B$20.6B10-Q 2026-02-09
Q4 2024
2024-09-30
$5.4B$400.0M$1.2B$1.7B$20.1B$20.2B10-K 2025-11-25

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B22026-05-13
Latest annual report10-K2025-11-25
Latest quarterly / interim10-Q2026-08-06
Latest current report8-K2026-11-05
Latest proxyDEFA14A2025-12-18

Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+2.9%
1 month+16.4%
3 months+19.8%
Year to date+42.9%
1 year+43.7%
From 52-week high0.0%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
BSXBoston Scientific Corporation$43.69-1.47%$63.3B
MDLNMedline Inc.$39.17-0.76%$51.5B
MMM3M Company$181.68-1.08%$93.9B
RMDResMed Inc.$238.19-0.56%$33.5B
DXCMDexCom Inc.$81.61-2.06%$30.4B
SYKStryker Corporation$310.72+0.35%$118.3B
WSTWest Pharmaceutical Services Inc.$417.80+0.33%$29.1B
SOLVSolventum Corporation$88.65-0.48%$15.0B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier